PURPOSE: To analyze the reasons and patient-related and injury-related risk factors for reoperation after surgery for acute subdural hematoma (SDH) and the effects of reoperation on treatment outcome. METHODS: Among adult patients operated on for acute SDH between 2013 and 2017, patients reoperated within 14 days after the primary surgery were identified. In all patients, parameters were identified that related to the patient (age, anticoagulation, antiplatelet, and antiepileptic treatment, and alcohol intoxication), trauma (Glasgow Coma Score, SDH thickness, midline shift, midline shift /hematoma thickness rate, other surgical lesion, primary surgery-trephination, craniotomy, or decompressive craniotomy), and Glasgow Outcome Score (GOS). The reasons for reoperation and intervals between primary surgery and reoperation were studied. RESULTS: Of 86 investigated patients, 24 patients were reoperated (27.9%), with a median interval of 2 days between primary surgery and reoperation. No significant differences in patients and injury-related factors were found between reoperated and non-reoperated patients. The rate of primary craniectomies was higher in non-reoperated patients (P = 0.066). The main indications for reoperation were recurrent /significant residual SDH (10 patients), contralateral SDH (5 patients), and expansive intracerebral hematoma or contusion (5 patients). The final median GOS was 3 in non-reoperated and 1.5 in reoperated patients, with good outcomes in 41.2% of non-reoperated and 16.7% of reoperated patients. CONCLUSIONS: Reoperation after acute SDH surgery is associated with a significantly worse prognosis. Recurrent /significant residual SDH and contralateral SDH are the most frequently found reasons for reoperation. None of the analyzed parameters were significant reoperation predictors.

Department of Neurosurgery Faculty of Medicine St Anne's Hospital Brno Masaryk University Pekařská 53 656 91 Brno Czech Republic

Faculty of Medicine Institute of Forensic Medicine Masaryk University Brno Czech Republic

Institute of Biostatistics and Analyses Masaryk University Medical Faculty Brno Czech Republic

Zobrazit více v PubMed

Korean J Neurotrauma. 2018 Apr;14(1):14-19 PubMed

J Trauma. 2011 Dec;71(6):1632-6 PubMed

World Neurosurg. 2017 Sep;105:749-754 PubMed

Neurol Med Chir (Tokyo). 2013;53(4):221-4 PubMed

J Neurol Surg A Cent Eur Neurosurg. 2017 Nov;78(6):535-540 PubMed

No Shinkei Geka. 2004 Mar;32(3):271-6 PubMed

Br J Neurosurg. 2017 Feb;31(1):78-83 PubMed

J Neurosurg. 2011 Jan;114(1):47-52 PubMed

World Neurosurg. 2016 Apr;88:569-575 PubMed

J Trauma. 2010 Jan;68(1):E11-2 PubMed

Exp Ther Med. 2015 Jul;10(1):225-230 PubMed

Cureus. 2016 May 20;8(5):e616 PubMed

Br J Neurosurg. 2000 Apr;14(2):110-6 PubMed

J Neurol Neurosurg Psychiatry. 2010 Nov;81(11):1275-9 PubMed

Acta Chir Orthop Traumatol Cech. 2014;81(1):77-84 PubMed

J Korean Neurosurg Soc. 2017 Nov;60(6):723-729 PubMed

World Neurosurg. 2018 Dec;120:e1024-e1030 PubMed

Neurosurg Rev. 2018 Apr;41(2):483-488 PubMed

Eur J Trauma Emerg Surg. 2013 Jun;39(3):277-83 PubMed

J Neurosurg. 2002 Jan;96(1):109-16 PubMed

World Neurosurg. 2017 May;101:335-342 PubMed

Korean J Neurotrauma. 2016 Oct;12(2):61-66 PubMed

J Clin Neurosci. 2013 Apr;20(4):509-13 PubMed

Surg Neurol. 2003 Jul;60(1):23-30; discussion 30 PubMed

BMC Surg. 2015 Oct 14;15:111 PubMed

J Neurosurg. 2015 Oct;123(4):1065-9 PubMed

Neurosurg Clin N Am. 2017 Apr;28(2):267-278 PubMed

Neurosurgery. 1994 Dec;35(6):1061-4; discussion 1064-5 PubMed

J Trauma. 2008 Dec;65(6):1298-302 PubMed

BMC Neurol. 2015 Oct 24;15:220 PubMed